发明名称 METHOD OF TREATING HCV INFECTION WITH A SMALL MOLECULE CHK2 INHIBITOR
摘要 A method of treating an Hepatitis C Virus infection in a patient, comprising providing a therapeutically effective amount, to a patient in need thereof, of a compound of Formula (I) or a pharmaceutically acceptable salt thereof, wherein: G1 is a group of the formula or where n is 0, 1, 2, 3, or 4 and Het is a 5- or 6-membered heteroaryl group containing 1 to 4 heteroatoms independently chosen from N, O, and S, which Het is optionally substituted.;
申请公布号 US2014294767(A1) 申请公布日期 2014.10.02
申请号 US201214353976 申请日期 2012.10.26
申请人 The United States of America, as Represented by The Secretary, Department of Health and Human Serv ;Provid Pharmaceuticals, Inc. 发明人 Waugh David;Self Christopher;Zhang Guangtao;Pommier Yves;Shoemaker Robert H.;Currens Michael;Cardellina John;Jobson Andrew;Lountos George;Scudiero Dominic
分类号 C07D403/12;A61K31/454;A61K31/4184;C12N9/96;A61K31/404;A61K45/06;A61K31/4709;A61K31/4178;C07D401/12;C07D209/42 主分类号 C07D403/12
代理机构 代理人
主权项 1. A method of treating an Hepatitis C Virus infection in a patient, comprising providing a therapeutically effective amount, to a patient in need thereof, of a compound of Formula I or a pharmaceutically acceptable salt thereof, wherein: G1 is a group of the formulawhere n is 0, 1, 2, 3, or 4 and Het is a 5- or 6-membered heteroaryl group containing 1 to 4 heteroatoms independently chosen from N, O, and S, which Het is optionally substituted; Ar1 is a 6,6-fused or 6,5 bicyclic aromatic ring system containing only carbon ring atoms or containing 1, 2, or 3 nitrogen ring atoms with remaining atoms being carbon, which Ar1 is optionally substituted, Ar2 is phenyl, a 6-membered heteroaryl ring containing 1 or 2 nitrogen ring atoms, or a 6,5 bicyclic aromatic ring system containing 1, 2, or 3, nitrogen atoms, with remaining atoms being carbon, which Ar2 is optionally substituted; R is a group of the formula —NH(C═O)— or —(O═C)NH—; R3 is hydrogen or C1-C6alkyl; R3 is taken together with an Ar2 substituent to form a 5- or 6-membered unsaturated or aromatic R3/Ar2 ring having 0, 1, or 2 heteroatoms independently chosen from N, O, and S, which R3/Ar2 ring is optionally substituted; R4 is hydrogen or C1-C6alkyl; R5 is amino, —NHOH, or optionally substituted mono- or di-alkylamino, and R6 is hydrogen or hydroxyl; or R5 and R6 are taken together to form a 5 or 6-membered heterocyclic ring, which is unsaturated or aromatic and which contains 0, 1, or 2 additional heteroatoms chosen from N, S, and O, which 5 or 6-membered heterocyclic ring is optionally substituted.
地址 Bethesda MD US